Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2971 studies found for:    Pulmonary Disease, Chronic Obstructive
Show Display Options
RSS Create an RSS feed from your search for:
Pulmonary Disease, Chronic Obstructive
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
2 Completed
Has Results
A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Placebo;   Biological: Benralizumab 100 mg
3 Unknown  Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Patient education and disease management
4 Terminated Portable Monitoring Device for the Diagnosis of Sleep Apnea in Patients With Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Obstructive Sleep Apnea Syndrome
Intervention: Device: Polysomnography
5 Completed A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: CNTO 6785;   Drug: Placebo
6 Completed Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® inhalets
7 Completed Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® inhalets
8 Completed Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® - inhalets
9 Completed Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® Inhalation Solution
10 Completed Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Atrovent® - inhalets
11 Completed Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Ventilat® - metered dose inhaler
12 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol xinafoate combination;   Drug: Other maintenance Treatments (OMT)
13 Completed Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Subjects with COPD;   Other: Subjects without COPD
14 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol xinafoate;   Drug: Anticholinergics
15 Terminated
Has Results
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: UK-432,097;   Drug: Placebo
16 Completed
Has Results
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS™ 250/50mcg;   Other: Placebo
17 Completed Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Atrovent®;   Drug: Ventilat®
18 Completed
Has Results
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone propionate/salmeterol combination product;   Drug: Salmeterol;   Drug: Placebo
19 Completed A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
20 Completed
Has Results
A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.